Annual EBIT
-$74.66 M
-$20.52 M-37.90%
December 31, 2023
Summary
- As of February 7, 2025, CABA annual earnings before interest & taxes is -$74.66 million, with the most recent change of -$20.52 million (-37.90%) on December 31, 2023.
- During the last 3 years, CABA annual EBIT has fallen by -$40.83 million (-120.67%).
- CABA annual EBIT is now -1105.55% below its all-time high of -$6.19 million, reached on December 31, 2018.
Performance
CABA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$33.05 M
-$2.77 M-9.14%
September 30, 2024
Summary
- As of February 7, 2025, CABA quarterly earnings before interest & taxes is -$33.05 million, with the most recent change of -$2.77 million (-9.14%) on September 30, 2024.
- Over the past year, CABA quarterly EBIT has dropped by -$5.01 million (-17.89%).
- CABA quarterly EBIT is now -1500.29% below its all-time high of -$2.06 million, reached on December 31, 2018.
Performance
CABA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$114.50 M
-$14.38 M-14.36%
September 30, 2024
Summary
- As of February 7, 2025, CABA TTM earnings before interest & taxes is -$114.50 million, with the most recent change of -$14.38 million (-14.36%) on September 30, 2024.
- Over the past year, CABA TTM EBIT has dropped by -$28.77 million (-33.55%).
- CABA TTM EBIT is now -3617.60% below its all-time high of -$3.08 million, reached on September 30, 2018.
Performance
CABA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CABA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.9% | -17.9% | -33.5% |
| 3 y3 years | -120.7% | -185.8% | -174.3% |
| 5 y5 years | -1105.5% | -556.9% | -512.9% |
CABA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -61.2% | at low | -180.6% | at low | -147.2% | at low |
| 5 y | 5-year | -299.6% | at low | -463.9% | at low | -512.9% | at low |
| alltime | all time | -1105.5% | at low | -1500.3% | at low | -3617.6% | at low |
Cabaletta Bio EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$33.05 M(+9.1%) | -$114.50 M(+14.4%) |
| Jun 2024 | - | -$30.28 M(+8.0%) | -$100.12 M(+16.8%) |
| Mar 2024 | - | -$28.03 M(+21.1%) | -$85.73 M(+14.8%) |
| Dec 2023 | -$74.66 M(+37.9%) | -$23.15 M(+24.0%) | -$74.66 M(+10.1%) |
| Sep 2023 | - | -$18.67 M(+17.5%) | -$67.82 M(+11.3%) |
| Jun 2023 | - | -$15.89 M(-6.3%) | -$60.93 M(+4.9%) |
| Mar 2023 | - | -$16.96 M(+4.0%) | -$58.10 M(+7.3%) |
| Dec 2022 | -$54.14 M(+16.9%) | -$16.30 M(+38.4%) | -$54.14 M(+4.7%) |
| Sep 2022 | - | -$11.78 M(-9.8%) | -$51.73 M(+0.4%) |
| Jun 2022 | - | -$13.06 M(+0.5%) | -$51.52 M(+3.9%) |
| Mar 2022 | - | -$13.00 M(-6.4%) | -$49.60 M(+7.1%) |
| Dec 2021 | -$46.31 M | -$13.89 M(+20.2%) | -$46.31 M(+10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$11.56 M(+3.8%) | -$41.75 M(+8.2%) |
| Jun 2021 | - | -$11.14 M(+14.8%) | -$38.60 M(+8.3%) |
| Mar 2021 | - | -$9.71 M(+4.1%) | -$35.65 M(+5.4%) |
| Dec 2020 | -$33.83 M(+81.1%) | -$9.33 M(+10.9%) | -$33.83 M(+11.4%) |
| Sep 2020 | - | -$8.42 M(+2.7%) | -$30.36 M(+12.5%) |
| Jun 2020 | - | -$8.19 M(+3.8%) | -$26.98 M(+19.4%) |
| Mar 2020 | - | -$7.89 M(+34.7%) | -$22.59 M(+20.9%) |
| Dec 2019 | -$18.68 M(+201.7%) | -$5.86 M(+16.5%) | -$18.68 M(+25.5%) |
| Sep 2019 | - | -$5.03 M(+32.3%) | -$14.89 M(+15.1%) |
| Jun 2019 | - | -$3.80 M(-4.7%) | -$12.94 M(+41.6%) |
| Mar 2019 | - | -$3.99 M(+93.2%) | -$9.13 M(+77.6%) |
| Dec 2018 | -$6.19 M | -$2.06 M(-33.0%) | -$5.14 M(+67.0%) |
| Sep 2018 | - | -$3.08 M | -$3.08 M |
FAQ
- What is Cabaletta Bio annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cabaletta Bio?
- What is Cabaletta Bio annual EBIT year-on-year change?
- What is Cabaletta Bio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cabaletta Bio?
- What is Cabaletta Bio quarterly EBIT year-on-year change?
- What is Cabaletta Bio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cabaletta Bio?
- What is Cabaletta Bio TTM EBIT year-on-year change?
What is Cabaletta Bio annual earnings before interest & taxes?
The current annual EBIT of CABA is -$74.66 M
What is the all time high annual EBIT for Cabaletta Bio?
Cabaletta Bio all-time high annual earnings before interest & taxes is -$6.19 M
What is Cabaletta Bio annual EBIT year-on-year change?
Over the past year, CABA annual earnings before interest & taxes has changed by -$20.52 M (-37.90%)
What is Cabaletta Bio quarterly earnings before interest & taxes?
The current quarterly EBIT of CABA is -$33.05 M
What is the all time high quarterly EBIT for Cabaletta Bio?
Cabaletta Bio all-time high quarterly earnings before interest & taxes is -$2.06 M
What is Cabaletta Bio quarterly EBIT year-on-year change?
Over the past year, CABA quarterly earnings before interest & taxes has changed by -$5.01 M (-17.89%)
What is Cabaletta Bio TTM earnings before interest & taxes?
The current TTM EBIT of CABA is -$114.50 M
What is the all time high TTM EBIT for Cabaletta Bio?
Cabaletta Bio all-time high TTM earnings before interest & taxes is -$3.08 M
What is Cabaletta Bio TTM EBIT year-on-year change?
Over the past year, CABA TTM earnings before interest & taxes has changed by -$28.77 M (-33.55%)